PolyActiva Raises AUD$9.2M in Series B Venture Funding

News   Feb 20, 2013

 
PolyActiva Raises AUD$9.2M in Series B Venture Funding
 
 
 

RELATED ARTICLES

Oligonucleotide Drug Producers Report on Drug Impurities

News

A new addition to a series of articles that focus on important topics related to the development of oligonucleotide therapeutics presents an in-depth look at the identification, characterization, and reporting of product-related impurities.

READ MORE

Uptake of Controlled Release Drug Delivery Technology Set to Increase?

News

The increasing access to healthcare facilities and the bolstering need for drugs to be used orally has been driving the consumption of generic drugs among people across the world, which, in turn, is fueling the need for controlled release technology for drug delivery to suffice the availability of drugs in small dosages.

READ MORE

New Drug Delivery System Targets Diseases at a Genetic Level

News

A new drug delivery system that uses a synthetic-biological hybrid nanocapsule could provide a smart technology for targeted treatment of a variety of serious diseases at the genetic level.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE